Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis
Clinical trial NCT03375047 · COMPLETED
Trial details
- NCT number
- NCT03375047
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-10
- Primary completion
- 2022-03-15
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.